Joseph K. Belanoff, MD, is the co-founder of Corcept Therapeutics, a pharmaceutical company focused on discovering, developing, and commercializing drugs that modulate the effects of cortisol to treat severe metabolic, oncologic, and psychiatric disorders.( He has served as Chief Executive Officer since 1999, a member of the Board of Directors, and was appointed President in 2014.( As CEO of Corcept Therapeutics Inc. (NASDAQ: CORT), he oversees operations from the company's headquarters in Redwood City, California, where it was founded in May 1998 alongside psychiatrist Alan Schatzberg.(

Dr. Belanoff is an Adjunct Professor of Psychiatry in the Department of Psychiatry and Behavioral Sciences at Stanford University, where he has held various positions since 1992.( He earned his BA from Amherst College and his MD from Columbia University’s College of Physicians & Surgeons.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.